A prothrombotic status is characteristic to HIV infection, and is associated with cardiovascular (CV) events and death. The consequences of HIV-related hypercoagulability may be even more severe in elderly, which are disproportionally affected by a prothrombotic status even in the absence of HIV infection. We reported similar coagulation abnormalities in nonhuman primate (NHP) models of AIDS in which increases of D-Dimer (DD) and thrombin-antithrombin complex (TAT) strongly predict disease progression and death. We also showed that, similar to humans, NHPs experience age-related increases of coagulation markers. A strong connection between coagulation and immune activation/inflammation (IA/INFL) markers exists in HIV- infected patients and SIV-infected NHPs. INFL induces expression of tissue factor (TF), a major activator of coagulation. In turn, coagulation factors enhance inflammatory signals via protease-activator receptors, maintaining a coagulation/INFL vicious cycle. Coagulation triggers fibrosis, which impedes CD4+ T cell restoration and may be a reason for ART failure. These observations, together with the finding that DD shows a strong independent risk for mortality in both HIV-infected patients and SIV-infected rhesus macaques (RMs), suggest that coagulation may play a central role in HIV pathogenesis and should be therapeutically targeted. We hypothesize that interventions aimed at limiting hypercoagulation in elderly HIV-infected patients will improve their clinical status an response to ART. We will therefore administer anticoagulants in young vs. older SIVmac-infected RMs with or without ART and assess the impact of these interventions on coagulation status, IA/INFL, fibrosis, CD4+ T cell restoration, CV comorbidities and death. We will use new and FDA- approved anticoagulants specifically targeting the extrinsic, intrinsic and common coagulation pathways. By comparing and contrasting the results of these approaches, we will gain insight into the mechanisms of SIV- and age-related hypercoagulability, independent of factors that usually confound human studies. Such in vivo mechanistic experiments cannot be performed in HIV-infected patients, particularly in older ones, due to the unknown risk of hemorrhages and death. With >50% of the US HIV-infected patients anticipated to be >50 years of age by 2015, the risk of noninfectious complications will be significantly higher and could become the main challenge for the management of chronic HIV infection. As such, our highly innovative, translational experiments address major gaps in our current knowledge of HIV pathogenesis in elderly. By improving the response to ART and preventing CV disease, a major cause of death in ART-treated patients, this research may have a major impact for the clinical management and survival of elderly HIV-infected patients.

Public Health Relevance

We propose a strategy for identification of the mechanisms responsible for increased severity of HIV pathogenesis in elders. Our strategy is based on the hypothesis that aging-related hypercoagulation enhances the risk for developing comorbidities, immune activation, inflammation and fibrosis and thus significantly reduces therapeutic success in elders treated with ART. We will confirm our hypothesis by interventions in SIV-infected NHPs aimed at normalizing hypercoagulation in old vs young animals. This highly translational research has the potential to: (i) establish a new therapeutic paradigm in older HIV infected patients that will prevent noninfectious complications of AIDS and may improve response to ART in this age category; (ii) validate biomarkers for the diagnostic and monitoring of HIV associated inflammation and/or disease progression in aging patients; (iii) contribute to the development of two new anticoagulant drugs that may be useful in numerous diseases affecting elders.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL123096-01A1
Application #
8983585
Study Section
Special Emphasis Panel (ZRG1-AARR-K (58))
Program Officer
Kindzelski, Andrei L
Project Start
2015-07-07
Project End
2019-06-30
Budget Start
2015-07-07
Budget End
2016-06-30
Support Year
1
Fiscal Year
2015
Total Cost
$753,695
Indirect Cost
$259,023
Name
University of Pittsburgh
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Kleinman, Adam J; Sivanandham, Ranjit; Pandrea, Ivona et al. (2018) Regulatory T Cells As Potential Targets for HIV Cure Research. Front Immunol 9:734
Brocca-Cofano, Egidio; Xu, Cuiling; Wetzel, Katherine S et al. (2018) Marginal Effects of Systemic CCR5 Blockade with Maraviroc on Oral Simian Immunodeficiency Virus Transmission to Infant Macaques. J Virol 92:
Policicchio, Benjamin Bruno; Sette, Paola; Xu, Cuiling et al. (2018) Emergence of resistance mutations in simian immunodeficiency virus (SIV)-infected rhesus macaques receiving non-suppressive antiretroviral therapy (ART). PLoS One 13:e0190908
Policicchio, Benjamin B; Cardozo, Erwing Fabian; Sette, Paola et al. (2018) Dynamics of Simian Immunodeficiency Virus Two-Long-Terminal-Repeat Circles in the Presence and Absence of CD8+ Cells. J Virol 92:
Brocca-Cofano, Egidio; Kuhrt, David; Siewe, Basile et al. (2017) Pathogenic Correlates of Simian Immunodeficiency Virus-Associated B Cell Dysfunction. J Virol 91:
He, Tianyu; Falwell, Elizabeth; Brocca-Cofano, Egidio et al. (2017) Modeling aging in HIV infection in nonhuman primates to address an emerging challenge of the post-ART era. Curr Opin Virol 25:66-75
Schechter, Melissa E; Andrade, Bruno B; He, Tianyu et al. (2017) Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy. Sci Transl Med 9:
Raehtz, Kevin; Pandrea, Ivona; Apetrei, Cristian (2016) The well-tempered SIV infection: Pathogenesis of SIV infection in natural hosts in the wild, with emphasis on virus transmission and early events post-infection that may contribute to protection from disease progression. Infect Genet Evol 46:308-323
Pandrea, Ivona; Xu, Cuiling; Stock, Jennifer L et al. (2016) Antibiotic and Antiinflammatory Therapy Transiently Reduces Inflammation and Hypercoagulation in Acutely SIV-Infected Pigtailed Macaques. PLoS Pathog 12:e1005384
Policicchio, Benjamin B; Pandrea, Ivona; Apetrei, Cristian (2016) Animal Models for HIV Cure Research. Front Immunol 7:12

Showing the most recent 10 out of 11 publications